These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33241290)

  • 1. Active vitamin D is cardioprotective in experimental uraemia but not in children with CKD Stages 3-5.
    Schön A; Leifheit-Nestler M; Deppe J; Fischer DC; Bayazit AK; Obrycki L; Canpolat N; Bulut IK; Azukaitis K; Yilmaz A; Mir S; Yalcinkaya F; Soylemezoglu O; Melk A; Stangl GI; Behnisch R; Shroff R; Bacchetta J; Querfeld U; Schaefer F; Haffner D;
    Nephrol Dial Transplant; 2021 Feb; 36(3):442-451. PubMed ID: 33241290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats.
    Leifheit-Nestler M; Grabner A; Hermann L; Richter B; Schmitz K; Fischer DC; Yanucil C; Faul C; Haffner D
    Nephrol Dial Transplant; 2017 Sep; 32(9):1493-1503. PubMed ID: 28339837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF23-Mediated Activation of Local RAAS Promotes Cardiac Hypertrophy and Fibrosis.
    Böckmann I; Lischka J; Richter B; Deppe J; Rahn A; Fischer DC; Heineke J; Haffner D; Leifheit-Nestler M
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nutritional vitamin D supplementation on markers of bone and mineral metabolism in children with chronic kidney disease.
    Lerch C; Shroff R; Wan M; Rees L; Aitkenhead H; Kaplan Bulut I; Thurn D; Karabay Bayazit A; Niemirska A; Canpolat N; Duzova A; Azukaitis K; Yilmaz E; Yalcinkaya F; Harambat J; Kiyak A; Alpay H; Habbig S; Zaloszyc A; Soylemezoglu O; Candan C; Rosales A; Melk A; Querfeld U; Leifheit-Nestler M; Sander A; Schaefer F; Haffner D; ;
    Nephrol Dial Transplant; 2018 Dec; 33(12):2208-2217. PubMed ID: 29481636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.
    Leifheit-Nestler M; Große Siemer R; Flasbart K; Richter B; Kirchhoff F; Ziegler WH; Klintschar M; Becker JU; Erbersdobler A; Aufricht C; Seeman T; Fischer DC; Faul C; Haffner D
    Nephrol Dial Transplant; 2016 Jul; 31(7):1088-99. PubMed ID: 26681731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
    Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of fibroblast growth factor-23 in cardiorenal syndrome.
    Kovesdy CP; Quarles LD
    Nephron Clin Pract; 2013; 123(3-4):194-201. PubMed ID: 23942553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages.
    Tanaka S; Fujita S; Kizawa S; Morita H; Ishizaka N
    PLoS One; 2016; 11(7):e0156860. PubMed ID: 27400031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system.
    Prié D; Friedlander G
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1717-22. PubMed ID: 20798257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.
    Tranæus Lindblad Y; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Bárány P
    Pediatr Nephrol; 2018 Jan; 33(1):147-157. PubMed ID: 28795324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor 23 is induced by an activated renin-angiotensin-aldosterone system in cardiac myocytes and promotes the pro-fibrotic crosstalk between cardiac myocytes and fibroblasts.
    Leifheit-Nestler M; Kirchhoff F; Nespor J; Richter B; Soetje B; Klintschar M; Heineke J; Haffner D
    Nephrol Dial Transplant; 2018 Oct; 33(10):1722-1734. PubMed ID: 29425341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.
    Wan M; Smith C; Shah V; Gullet A; Wells D; Rees L; Shroff R
    Nephrol Dial Transplant; 2013 Jan; 28(1):153-61. PubMed ID: 23180879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced renal α-Klotho expression in CKD patients and its effect on renal phosphate handling and vitamin D metabolism.
    Sakan H; Nakatani K; Asai O; Imura A; Tanaka T; Yoshimoto S; Iwamoto N; Kurumatani N; Iwano M; Nabeshima Y; Konishi N; Saito Y
    PLoS One; 2014; 9(1):e86301. PubMed ID: 24466013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
    Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
    Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of novel vitamin D receptor analog VS-105 and paricalcitol on chronic kidney disease-mineral bone disorder in an experimental model of chronic kidney disease.
    Fujii H; Yonekura Y; Nakai K; Kono K; Goto S; Nishi S
    J Steroid Biochem Mol Biol; 2017 Mar; 167():55-60. PubMed ID: 27818277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mineral metabolism in patients on chronic peritoneal dialysis].
    Ceballos O ML; Rojo L A; Azócar P M; Ibacache M MJ; Delucchi B A; Quiroz Z L; Irarrázabal M C; Delgado B I; Ugarte P F; Cano Sch F
    Rev Chil Pediatr; 2014 Feb; 85(1):31-9. PubMed ID: 25079181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease.
    de Borst MH; Vervloet MG; ter Wee PM; Navis G
    J Am Soc Nephrol; 2011 Sep; 22(9):1603-9. PubMed ID: 21852584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular mass progression despite stable blood pressure and kidney function in stage 3 chronic kidney disease.
    Seifert ME; de Las Fuentes L; Ginsberg C; Rothstein M; Dietzen DJ; Cheng SC; Ross W; Windus D; Dávila-Román VG; Hruska KA
    Am J Nephrol; 2014; 39(5):392-9. PubMed ID: 24818573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast Growth Factor 23 as Regulator of Vitamin D Metabolism.
    Nakatani S; Nakatani A; Mori K; Emoto M; Inaba M; Razzaque MS
    Adv Exp Med Biol; 2022; 1362():47-54. PubMed ID: 35288872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Land of Controversy: Fibroblast Growth Factor-23 and Uremic Cardiac Hypertrophy.
    Bao JF; Hu PP; She QY; Li A
    J Am Soc Nephrol; 2020 Jul; 31(7):1423-1434. PubMed ID: 32527977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.